(Q45139069)

9 December 2017

BNP and ANP as diagnostic and predictive markers in heart failure with left ventricular systolic dysfunction (English)

1 reference

9 December 2017

1 reference

1 reference

Luiz Menezes Falcão

1

1 reference

9 December 2017

Fausto Pinto

series ordinal

2

1 reference

9 December 2017

Luciano Ravara

series ordinal

3

1 reference

9 December 2017

Peter Adriaan van Zwieten

series ordinal

4

1 reference

9 December 2017

language of work or name

1 reference

1 September 2004

1 reference

Journal of the Renin-Angiotensin-Aldosterone System

9 December 2017

1 reference

9 December 2017

5

1 reference

9 December 2017

3

1 reference

9 December 2017

121-129

1 reference

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

9 December 2017

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.028

Impact of left ventricular cavity size on survival in advanced heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.028

Accuracy of exercise 201Tl myocardial scintigraphy in asymptomatic young men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.028

The erythrocyte sedimentation rate in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.028

Analysis of deaths in patients awaiting heart transplantation: impact on patient selection criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.028

Factors predicting mortality in idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.028

Transplant candidates with severe left ventricular dysfunction managed with medical treatment: characteristics and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.028

Relation between gender, etiology and survival in patients with symptomatic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.028

Wasting as independent risk factor for mortality in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.028

Prognostic value of heart rate variability in chronic congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.028

Biochemical detection of left-ventricular systolic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.028

Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.028

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.028

Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.028

Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.028

Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.028

Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.028

The Neurohumoral Axis in Congestive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.028

Endogenous catecholamine levels in chronic heart failure. Relation to the severity of hemodynamic abnormalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.028

Long-term predictors of sudden and low output death in chronic congestive heart failure secondary to coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.028

Prognostic value of plasma soluble intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.028

Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.028

Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.028

Plasma Atrial Natriuretic Peptide Level As an Index for the Severity of Congestive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.028

21 January 2018

Identifiers

DOI

10.3317/JRAAS.2004.028

0 references

1 reference